An interlaboratory comparison of the FDA protocol for the evaluation of cavitation potential of mechanical heart valves.
Five laboratories carried out measurements of cavitation threshold for a common set of six mechanical prosthetic heart valves, two each from three different manufacturers. This study was intended to evaluate to what extent FDA's current guidance for cavitation testing would lead to consistent results in a variety of laboratory settings and to seek areas for improvement in the recommended test protocol. The inter-laboratory study protocol specified: (1) characterization of the test fluid by oxygen content and electrical conductivity, (2) location and frequency response of pressure sensors, (3) determination of ventricular and atrial pressures (P) and loading rates (dP/dt) averaged over the time period of valve closure and over the time periods of 1 ms, 5 ms, and 20 ms prior to video visualization. The protocol did not specify: (1) the fluid pumping equipment to be used to generate cavitation, (2) the pump or fluid parameters adjusted to raise or lower the loading rate, (3) the equipment, technique, or sensitivity used to visualize cavitation, and (4) a specific definition of the threshold for cavitation. Results from the five laboratories are reported. Significant differences in results were observed in dP/dt and in the pressure difference across the valves during closure at cavitation threshold. Specific differences in test systems included a wide range of ventricular compliance and single valved versus double valved test systems. Three single valve systems with compliant ventricles produced results in reasonable agreement with one another. Further similarity in test equipment should be specified to assure adequate interlaboratory reliability for cavitation testing. Areas needing better specification include the design of the valve mount, the design of the cavitation generators, and qualitative criteria for detection of threshold cavitation.
Carey
R F
RF
Food and Drug Administration, Rockville, MD 20857, USA.
Porter
J M
JM
Richard
G
G
Luck
C
C
Shu
M C
MC
Guo
G X
GX
Elizondo
D R
DR
Kingsbury
C
C
Anderson
S
S
Herman
B A
BA
D001672:Biocompatible Materials; D002244:Carbon; D005069:Evaluation Studies as Topic; D006350:Heart Valve Prosthesis; D006801:Humans; D008422:Materials Testing / Q000295:instrumentation / Q000379:methods / Q000592:standards*; D011474:Prosthesis Design; D011475:Prosthesis Failure; D013314:Stress, Mechanical; D014481:United States; D014486:United States Food and Drug Administration / Q000592:standards
D001672:Biocompatible Materials; C009139:pyrolytic carbon; D002244:Carbon